Reference list
1. Goebel A. Complex regional pain syndrome in adults. Rheumatology (Oxford). 2011;50(10):1739-50.
2. Shim H, Rose J, Halle S, Shekane P. Complex regional pain syndrome: a narrative review for the practising clinician. Br J Anaesth. 2019;123(2):e424-e33.
3. Smart KM, Wand BM, O’Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev. 2016;2(2):Cd010853.
4. de Rooij AM, Perez RS, Huygen FJ, van Eijs F, van Kleef M, Bauer MC, et al. Spontaneous onset of complex regional pain syndrome. Eur J Pain. 2010;14(5):510-3.
5. Johnson S, Cowell F, Gillespie S, Goebel A. Complex regional pain syndrome what is the outcome? - a systematic review of the course and impact of CRPS at 12 months from symptom onset and beyond. Eur J Pain. 2022;26(6):1203-20.
6. de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129(1-2):12-20.
7. Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain. 2003;103(1-2):199-207.
8. Harden RN, McCabe CS, Goebel A, Massey M, Suvar T, Grieve S, et al. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition. Pain Med. 2022;23(Suppl 1):S1-s53.
9. Robinson CL, Fonseca ACG, Diejomaoh EM, D’Souza RS, Schatman ME, Orhurhu V, et al. Scoping Review: The Role of Psychedelics in the Management of Chronic Pain. J Pain Res. 2024;17:965-73.
10. Elsamadicy AA, Yang S, Sergesketter AR, Ashraf B, Charalambous L, Kemeny H, et al. Prevalence and Cost Analysis of Complex Regional Pain Syndrome (CRPS): A Role for Neuromodulation. Neuromodulation. 2018;21(5):423-30.
11. Lyes M, Yang KH, Castellanos J, Furnish T. Microdosing psilocybin for chronic pain: a case series. Pain. 2023;164(4):698-702.
12. Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Lindsey H, et al. Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. Neurotherapeutics. 2021;18(1):534-43.
13. Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y, et al. Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. Headache. 2022;62(10):1383-94.
14. Siegel JS, Daily JE, Perry DA, Nicol GE. Psychedelic Drug Legislative Reform and Legalization in the US. JAMA Psychiatry. 2023;80(1):77-83.
15. Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, et al. Use of Psychedelics for Pain: A Scoping Review. Anesthesiology. 2023;139(4):523-36.
16. Brown CA, Scholtes I, Shenker N, Lee MC. Suboptimal learning of tactile-spatial predictions in patients with complex regional pain syndrome. Pain. 2020;161(2):369-78.
17. Watson HK, Carlson L. Treatment of reflex sympathetic dystrophy of the hand with an active ”stress loading” program. J Hand Surg Am. 1987;12(5 Pt 1):779-85.
18. Ramachandran V, Chunharas C, Marcus Z, Furnish T, Lin A. Relief from intractable Phantom pain by combining psilocybin and mirror visual-feedback (MVF). Neurocase. 2018 Mar 4;24(2):105–10. doi:10.1080/13554794.2018.1468469